Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age
New England Journal of Medicine (2022) - Comments
pubmed: 34752019  doi: 10.1056/nejmoa2116298  issn: 0028-4793  issn: 1533-4406 

Emmanuel B. Walter, Kawsar R. Talaat, Charu Sabharwal, Alejandra Gurtman, Stephen Lockhart, Grant C. Paulsen, Elizabeth D. Barnett, Flor M. Muñoz, Yvonne Maldonado, Barbara A. Pahud, Joseph B. Domachowske, Eric A.F. Simões, Uzma N. Sarwar, Nicholas Kitchin, Luke Cunliffe, Pablo Rojo, Ernest Kuchar, Mika Rämet, Iona Munjal, John L. Perez